Great post! Polypharmacy is a significant challenge, especially in older patients. There is a high possibility of medication interactions, side effects, and reduced medication adherence due to the complexity of treatment regimens. There is also a wealth of free information about medications available online. Additionally, Google has been investing in medical LLM models. I believe, as suggested in your post, that some big tech companies will eventually create a multimodal model capable of integrating data from lab tests, medication package inserts, and EHRs. As someone with a background in pharmacy, I am excited about these advancements.
I think we will see what you describe in the next ten years. The challenge is going to be reimbursement as the adoption of these technologies will have to be factored into payment models in both government and commercial markets!
Great post! Polypharmacy is a significant challenge, especially in older patients. There is a high possibility of medication interactions, side effects, and reduced medication adherence due to the complexity of treatment regimens. There is also a wealth of free information about medications available online. Additionally, Google has been investing in medical LLM models. I believe, as suggested in your post, that some big tech companies will eventually create a multimodal model capable of integrating data from lab tests, medication package inserts, and EHRs. As someone with a background in pharmacy, I am excited about these advancements.
I think we will see what you describe in the next ten years. The challenge is going to be reimbursement as the adoption of these technologies will have to be factored into payment models in both government and commercial markets!